Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huasu Yuchuang Mouthwash is a topical oral rinse developed by Beijing Wellso Pharmaceutical, a subsidiary of Sihuan Pharmaceutical. It is part of the "Huasu" brand series, which is prominent in the Chinese oral care market. The product is formulated as a small molecule solution intended for the symptomatic relief of oral conditions such as oral ulcers, gingivitis, and general mucosal inflammation. It is designed to promote the healing of oral wounds and provide antiseptic and anti-inflammatory benefits. While some sources translate the name as "Huasu Guaifenesin Mouthwash," the "Yuchuang" (healing) designation in Chinese pharmaceutical contexts often refers to mucosal repair agents like guaiazulene. The product is currently approved and marketed in China for oral hygiene and the treatment of symptomatic oral conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huasu Yuchuang Mouthwash.